SCHEMBL4339264

SCHEMBL4339264

CC(C)OC(Cc1cccc(NC(=O)C(C)Oc2ccc(Cl)cc2Cl)c1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.63
LMNA P02545 5/20 0.56
HPGD P15428 4/20 0.56
PPARA Q07869 2/20 0.55
ALDH1A1 P00352 5/20 0.55
GAA P10253 3/20 0.55
KDM4E B2RXH2 2/20 0.55
TSHR P16473 1/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 2/20 0.54
MAPT P10636 5/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
SMN1; SMN2 Q16637 3/20 0.51
TP53 P04637 1/20 0.51
ALOX12 P18054 1/20 0.47
POLB P06746 1/20 0.47
PPARG P37231 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4341786 0.89 PPARA (0.54) PKMLMNAHPGDPPARAALDH1A1
SCHEMBL4328777 0.85 RAB9A (0.54) PKMLMNAHPGDPPARAALDH1A1
SCHEMBL4343560 0.84 MAPT (0.57) PKMLMNAHPGDPPARAALDH1A1
SCHEMBL4331663 0.82 SMN1; SMN2 (0.50) PKMLMNAHPGDPPARAALDH1A1
SCHEMBL4335009 0.79 ALDH1A1 (0.45) HPGDPPARAALDH1A1GAATSHR
SCHEMBL13819716 0.79 MRGPRX4 (0.59) HPGDPPARAALDH1A1HTTMAPT
SCHEMBL13819776 0.79 MRGPRX4 (0.59) HPGDPPARAALDH1A1HTTMAPT
SCHEMBL4328049 0.78 ALDH1A1 (0.48) LMNAHPGDPPARAALDH1A1GAA
SCHEMBL4339301 0.76 PPARA (0.54) LMNAHPGDPPARAALDH1A1TSHR
SCHEMBL4336847 0.76 PPARA (0.54) HPGDPPARATSHRMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 PKM 4339/4885LMNA 3790/4885HPGD 2910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.